Dark
Light
Today: May 22, 2024
January 7, 2024
1 min read

Tech Investment Alliance: Tsangs Group and PIF-backed Developer Join Forces

TLDR:

Hong Kong single family office Tsangs Group is teaming up with Saudi Arabia’s Public Investment Fund-owned ROSHN Group to facilitate technology venture capital investments in areas such as renewable energy and robotics. The collaboration aims to create an ecosystem and bilateral investment pipelines between Hong Kong, the Greater Bay Area (GBA), and Saudi Arabia, with a focus on key investment sectors such as smart city, healthcare, sustainability, artificial intelligence, robotics, new materials, biotech, and fintech. ROSHN Group will help expand impactful technology companies from Hong Kong into Saudi markets, while Tsangs Group and the Hong Kong Ambassadors Club (HKAC) will support ROSHN Group to identify and partner with tech companies in Hong Kong and the GBA.

Key points:

  • Hong Kong single family office Tsangs Group is collaborating with Saudi Arabia’s Public Investment Fund-owned ROSHN Group to facilitate technology venture capital investments in areas such as renewable energy and robotics.
  • The collaboration aims to create an ecosystem and bilateral investment pipelines between Hong Kong, the Greater Bay Area (GBA), and Saudi Arabia to strengthen both Saudi Arabia and Hong Kong as global technology hubs.
  • The partnership will focus on tech investments in areas such as smart city, healthcare, sustainability, artificial intelligence, robotics, new materials, biotech, and fintech.
  • ROSHN Group will facilitate the expansion of impactful technology companies from Hong Kong into Saudi markets, while Tsangs Group and HKAC will support ROSHN Group to identify and partner with tech companies in Hong Kong and the GBA.
Previous Story

nullFueling Early-Stage Fintech Innovators: Boosting Funding Avenues for Startups”

Next Story

Opportunities for Clinicians: Exploring the Thriving Startup Scene

Latest from Blog

LabGenius Secures £35 Million in Series B Round

TLDR: LabGenius, a London-based drug discovery company, raised £35M in Series B funding led by M Ventures. The company plans to use the funds to further develop its machine learning-driven drug discovery
Go toTop